CVRx (CVRX) News Today $12.50 +0.39 (+3.22%) (As of 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period CVRx to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 23 at 4:30 PM | globenewswire.comThis device saved a former Mid-South minister from heart failureDecember 19, 2024 | msn.comStrong Growth Outlook for CVRx: Buy Rating Supported by Strategic Adjustments and Market PotentialDecember 17, 2024 | markets.businessinsider.comWilliam Blair Forecasts CVRx's FY2026 Earnings (NASDAQ:CVRX)December 17, 2024 | americanbankingnews.comWhat is William Blair's Forecast for CVRx FY2026 Earnings?CVRx, Inc. (NASDAQ:CVRX - Free Report) - Investment analysts at William Blair issued their FY2026 earnings per share (EPS) estimates for shares of CVRx in a report issued on Friday, December 13th. William Blair analyst M. Andrew expects that the company will post earnings of ($1.91) per share forDecember 16, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of "Moderate Buy" by BrokeragesCVRx, Inc. (NASDAQ:CVRX - Get Free Report) has received a consensus rating of "Moderate Buy" from the seven analysts that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The avDecember 12, 2024 | marketbeat.comCVRx price target raised to $22 from $17 at CanaccordDecember 9, 2024 | markets.businessinsider.comEvaluating CVRx: Insights From 6 Financial AnalystsDecember 9, 2024 | benzinga.comCVRx (NASDAQ:CVRX) Price Target Raised to $22.00Canaccord Genuity Group raised their target price on shares of CVRx from $17.00 to $22.00 and gave the stock a "buy" rating in a research report on Monday.December 9, 2024 | marketbeat.comFY2024 EPS Estimates for CVRx Lifted by Cantor FitzgeraldCVRx, Inc. (NASDAQ:CVRX - Free Report) - Investment analysts at Cantor Fitzgerald increased their FY2024 earnings per share estimates for CVRx in a research report issued to clients and investors on Tuesday, December 3rd. Cantor Fitzgerald analyst R. Osborn now forecasts that the company will earDecember 5, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Shares Purchased by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC boosted its holdings in shares of CVRx, Inc. (NASDAQ:CVRX - Free Report) by 52.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 682,897 shares of the company's stock afterDecember 4, 2024 | marketbeat.comPDT Partners LLC Invests $543,000 in CVRx, Inc. (NASDAQ:CVRX)PDT Partners LLC purchased a new stake in CVRx, Inc. (NASDAQ:CVRX - Free Report) during the third quarter, according to its most recent disclosure with the SEC. The firm purchased 61,657 shares of the company's stock, valued at approximately $543,000. PDT Partners LLC owned approximately 0.25% of CDecember 3, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Insider Paul Verrastro Sells 1,430 SharesNovember 22, 2024 | insidertrades.comPaul Verrastro Sells 1,430 Shares of CVRx, Inc. (NASDAQ:CVRX) StockCVRx, Inc. (NASDAQ:CVRX - Get Free Report) insider Paul Verrastro sold 1,430 shares of CVRx stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $13.58, for a total transaction of $19,419.40. Following the sale, the insider now owns 1,875 shares of the company's stock, valued at approximately $25,462.50. The trade was a 43.27 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.November 21, 2024 | marketbeat.comCVRx to Present at the Piper Sandler 36th Annual Healthcare ConferenceNovember 20, 2024 | globenewswire.comCVRx, Inc. (NASDAQ:CVRX) Given Consensus Rating of "Moderate Buy" by AnalystsCVRx, Inc. (NASDAQ:CVRX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The averaNovember 17, 2024 | marketbeat.comInternational Assets Investment Management LLC Purchases Shares of 38,324 CVRx, Inc. (NASDAQ:CVRX)International Assets Investment Management LLC purchased a new stake in CVRx, Inc. (NASDAQ:CVRX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 38,324 shares of the company's stock, vaNovember 7, 2024 | marketbeat.comCVRx: Impressive Top-Line Growth Seems Priced InNovember 6, 2024 | seekingalpha.comCVRx (CVRX) Gets a Buy from Lake StreetNovember 5, 2024 | markets.businessinsider.comCVRx price target raised to $20 from $15 at Craig-HallumNovember 5, 2024 | markets.businessinsider.comCVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025November 4, 2024 | finance.yahoo.comCraig Hallum Issues Positive Forecast for CVRx (NASDAQ:CVRX) Stock PriceCraig Hallum raised their target price on shares of CVRx from $15.00 to $20.00 and gave the stock a "buy" rating in a research report on Monday.November 4, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Shares Sold by Emerald Advisers LLCEmerald Advisers LLC lessened its holdings in shares of CVRx, Inc. (NASDAQ:CVRX - Free Report) by 10.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 403,054 shares of the company's stock aftNovember 4, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next YearNovember 1, 2024 | finance.yahoo.comCantor Fitzgerald Brokers Cut Earnings Estimates for CVRxCVRx, Inc. (NASDAQ:CVRX - Free Report) - Equities researchers at Cantor Fitzgerald decreased their FY2024 earnings per share (EPS) estimates for shares of CVRx in a report released on Wednesday, October 30th. Cantor Fitzgerald analyst R. Osborn now expects that the company will earn ($2.59) per sNovember 1, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Q3 2024 Earnings Call TranscriptOctober 31, 2024 | msn.comCVRx, Inc.: CVRx Reports Third Quarter 2024 Financial and Operating ResultsOctober 31, 2024 | finanznachrichten.deCVRx price target raised to $16 from $13 at Piper SandlerOctober 31, 2024 | markets.businessinsider.comCVRx: Strong Financial Performance and Strategic Advancements Support Buy RatingOctober 31, 2024 | markets.businessinsider.comCVRx (NASDAQ:CVRX) Given New $15.00 Price Target at Lake Street CapitalLake Street Capital lifted their price objective on CVRx from $12.00 to $15.00 and gave the company a "buy" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comPiper Sandler Reaffirms Overweight Rating for CVRx (NASDAQ:CVRX)Piper Sandler restated an "overweight" rating and set a $16.00 target price (up from $13.00) on shares of CVRx in a research report on Wednesday.October 30, 2024 | marketbeat.comCVRx Inc (CVRX) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising ExpensesOctober 30, 2024 | finance.yahoo.comCVRx Reports Third Quarter 2024 Financial and Operating ResultsOctober 29, 2024 | markets.businessinsider.comInsights into CVRx's Upcoming EarningsOctober 29, 2024 | benzinga.comLake Street Sticks to Its Buy Rating for CVRx (CVRX)October 29, 2024 | markets.businessinsider.comCraig-Hallum Sticks to Their Buy Rating for CVRx (CVRX)October 29, 2024 | markets.businessinsider.comEarnings To Watch: CVRx Inc (CVRX) Reports Q3 2024 ResultOctober 28, 2024 | finance.yahoo.comCVRx (NASDAQ:CVRX) Receives "Overweight" Rating from Cantor FitzgeraldCantor Fitzgerald reissued an "overweight" rating and set a $14.00 price objective on shares of CVRx in a report on Wednesday.October 23, 2024 | marketbeat.comCVRx, Inc. (NASDAQ:CVRX) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of CVRx, Inc. (NASDAQ:CVRX - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have given a buy rating toOctober 23, 2024 | marketbeat.comCVRx receives Category I code for Barostim, says Cantor FitzgeraldOctober 22, 2024 | markets.businessinsider.comCVRx’s Category I CPT Code Acceptance Boosts Buy Rating Amidst Reimbursement ChallengesOctober 22, 2024 | markets.businessinsider.comCVRx announces new CPT Category I codes for Barostim heart failure therapyOctober 21, 2024 | finance.yahoo.comCVRX Dec 2025 10.000 call (CVRX251219C00010000)October 20, 2024 | finance.yahoo.comCVRx announces new CPT Category I codes for BarostimOctober 20, 2024 | finance.yahoo.comCVRx announces new CPT® Category I codes for BarostimOctober 18, 2024 | globenewswire.comCVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024October 15, 2024 | globenewswire.comLake Street Reaffirms Their Buy Rating on Artivion (AORT)October 11, 2024 | markets.businessinsider.comCraig-Hallum Sticks to Its Buy Rating for MiMedx Group (MDXG)October 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Certara (CERT) and CVRx (CVRX)October 7, 2024 | markets.businessinsider.comCVRx (CVRX) Gets a Buy from Craig-HallumOctober 3, 2024 | markets.businessinsider.com Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. CVRX Media Mentions By Week CVRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CVRX News Sentiment▼1.090.59▲Average Medical News Sentiment CVRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CVRX Articles This Week▼63▲CVRX Articles Average Week Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BLFS News Today PLSE News Today AORT News Today EMBC News Today CBLL News Today LQDA News Today EYE News Today BVS News Today FNA News Today AVNS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CVRX) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CVRX Stock Alerts